News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• May 11, 2004

  Insmed to Present at Rodman and Renshaw Healthcare Conference May 13, 2004; Presentation to Be Webcast Live
• May 5, 2004

  Insmed Incorporated Reports Financial Results for First Quarter of 2004
• Apr 29, 2004

  Insmed Incorporated to Webcast First Quarter Earnings Conference Call; Thursday, May 6, at 11:00 a.m. ET - 10:00 a.m. CT
• Apr 14, 2004

  Insmed Acquires Manufacturing Facility from Baxter International
• Mar 23, 2004

  Insmed to Present at Wells Fargo Securities Healthcare Conference
• Mar 23, 2004

  Insmed to Present at Wells Fargo Securities Healthcare Conference; Presentation to Be Webcast Live
• Feb 11, 2004

  Insmed Incorporated Reports Improved Financial Results for Fourth Quarter 2003 and Twelve-Months Ended December 31, 2003
• Feb 4, 2004

  Insmed Inc. to Webcast Fourth Quarter Earnings Conference Call; Wednesday, February 11, at 11:00 a.m. ET - 10:00 a.m. CT
• Jan 26, 2004

  Insmed Obtains Patent Rights for Extreme Insulin Resistance From Fujisawa
• Dec 15, 2003

  Insmed Receives FDA Orphan Drug Designation For rhIGF-I/rhIGFBP-3, SomatoKine, for Extreme Insulin Resistance
• Dec 3, 2003

  Insmed Presents Positive Data on Anti-Cancer Drug Candidate to San Antonio Breast Cancer Symposium
• Dec 2, 2003

  rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes

  rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes
• Nov 17, 2003

  Insmed Presents Positive Data on Anti-Cancer Drug Candidate to AACR-NCI-EORTC
• Nov 5, 2003

  Insmed to Present Cancer Data to CaP Cure, the Prostate Cancer Foundation
• Nov 5, 2003

  Insmed Incorporated Reports Financial Results for Third Quarter 2003 and Nine-Months Ended September 30, 2003
• Oct 28, 2003

  Insmed Incorporated to Webcast Third Quarter Earnings Conference Call; Wednesday, November 5, at 11:00 a.m. ET - 10:00 a.m. CT
• Oct 16, 2003

  Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live

  Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live
• Sep 23, 2003

  Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer

  Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer
• Sep 15, 2003

  Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology

  Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology
• Sep 5, 2003

  Company Profile for Insmed Incorporated

  Company Profile for Insmed Incorporated
• Jul 31, 2003

  Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003

  Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003
• Jul 24, 2003

  Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT

  Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT
• Jul 16, 2003

  Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported

  Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported
• Jul 14, 2003

  Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer

  Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer
• Jul 11, 2003

  Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities

  Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download